ARROWHEAD PHARMACEUTICALS, INC. (ARWR) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ARWR currently has 142M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 21.81% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 142.4M shares outstanding |
140M | 0 |
| Nov 25, 2025 |
10-K filing | 133.8M shares outstanding |
130M | 0 |
| Aug 07, 2025 |
10-Q filing | 139.0M shares outstanding |
140M | 0 |
| May 12, 2025 |
10-Q filing | 134.5M shares outstanding |
130M | 0 |
| Feb 10, 2025 |
10-Q filing | 124.8M shares outstanding |
120M | 0 |
| Nov 26, 2024 |
10-K filing | 119.8M shares outstanding |
120M | 0 |
| Aug 08, 2024 |
10-Q filing | 124.2M shares outstanding |
120M | 0 |
| May 09, 2024 |
10-Q filing | 123.3M shares outstanding |
120M | 0 |
| Feb 06, 2024 |
10-Q filing | 123.9M shares outstanding |
120M | 0 |
| Jan 04, 2024 |
8-K filing: Arrowhead Pharmaceuticals, Inc. entered into an underwriting agreement to issue and sell 15,790,000 shares of common stock at $28.50 per share, with net proceeds estimated at $429.0 million for research and development, general corporate expenses, and working capital needs; the offering is expected to close on January 5, 2024. ($450.02M proceeds) |
110M | 0 |
| Nov 29, 2023 |
10-K filing | 106.8M shares outstanding |
110M | 0 |
| Aug 07, 2023 |
10-Q filing | 107.0M shares outstanding |
110M | 0 |
| May 02, 2023 |
10-Q filing | 106.8M shares outstanding |
110M | 0 |
| Feb 06, 2023 |
10-Q filing | 106.0M shares outstanding |
110M | 0 |
| Dec 08, 2022 |
8-K filing: Arrowhead Pharmaceuticals, Inc. entered into an open market sale agreement with Jefferies LLC to issue and sell up to 7,807,620 shares of common stock, with estimated gross proceeds of approximately $250 million, and the offering closed on December 2, 2022. ($250.0M proceeds) |
110M | 0 |
| Nov 28, 2022 |
10-K filing | 105.4M shares outstanding |
110M | 0 |
| Aug 04, 2022 |
10-Q filing | 105.8M shares outstanding |
110M | 0 |
| May 10, 2022 |
10-Q filing | 105.5M shares outstanding |
110M | 0 |
| Feb 02, 2022 |
10-Q filing | 104.5M shares outstanding |
100M | 0 |
| Nov 22, 2021 |
10-K filing | 103.7M shares outstanding |
100M | 0 |
| Aug 05, 2021 |
10-Q filing | 104.1M shares outstanding |
100M | 0 |
| May 04, 2021 |
10-Q filing | 103.9M shares outstanding |
100M | 0 |
| Feb 04, 2021 |
10-Q filing | 102.8M shares outstanding |
100M | 0 |
| Nov 23, 2020 |
10-K filing | 100.7M shares outstanding |
100M | 0 |
| Aug 05, 2020 |
10-Q filing | 101.8M shares outstanding |
100M | 0 |
| May 07, 2020 |
10-Q filing | 101.7M shares outstanding |
100M | 0 |
| Feb 05, 2020 |
10-Q filing | 97.1M shares outstanding |
97M | 0 |